Plasma lipoprotein(a) levels and atherosclerotic renal artery stenosis in hypertensive patients

Kidney and Blood Pressure Research

Volumn 40, Issue 2, 2015, Pages 166-175

  Catena, Cristiana ^a   Colussi, Gianluca ^a   Nait, Francesca ^a   Capobianco, Frine ^a   Sechi, Leonardo A ^a  

^a UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

Homocysteine; Ischemic nephropathy; Lipoprotein(a); Prothrombotic state; Renovascular hypertension

Indexed keywords

FIBRINOLYTIC AGENT; HEMOSTATIC AGENT; HOMOCYSTEINE; LIPOPROTEIN A;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC RENAL ARTERY STENOSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; DISEASE DURATION; FEMALE; HUMAN; HYPERTENSION; INVESTIGATIVE PROCEDURES; ISCHEMIC HEART DISEASE; KIDNEY ANGIOGRAPHY; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SMOKING; BLOOD; COMPLICATION; CROSS-SECTIONAL STUDY; FIBRINOLYSIS; HEMOSTASIS; KIDNEY FUNCTION TEST; MIDDLE AGED; PATHOLOGY; RENAL ARTERY OBSTRUCTION; RISK FACTOR;

AGED; ATHEROSCLEROSIS; CROSS-SECTIONAL STUDIES; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMANS; HYPERTENSION; KIDNEY FUNCTION TESTS; LIPOPROTEIN(A); MALE; MIDDLE AGED; RENAL ARTERY OBSTRUCTION; RISK FACTORS;

EID: 84927926914     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000368492     Document Type: Article

References (47)

1. Hansen KJ, Edwards MS, Craven TE, Cherr GS, Jackson SA, Appel RG, Burke GL, Dean RH: Prevalence of renovascular disease in the elderly: A population-based study. J Vasc Surg 2002;36:443-451.
2. Cohen MG, Pascua JA, Garcia-Ben M, Rojas-Matas CA, Gabay JM, Berrocal DH, Tan WA, Stouffer GA, Montoya M, Fernandez AD, Halac ME, Grinfeld LR: A simple prediction rule for significant renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J 2005;150:1204-1211.
3. Mui KW, Sleewijk M, van den Hout H, Van Baal J, Navis G, Woittiez AJ: Incidental renal artery stenosis. J Am Soc Nephrol 2006;17:2069-2074.
4. Safian RD, Textor SC: Renal-artery stenosis. N Engl J Med 2001;344:431-442.
5. Working Group on Renovascular Hypertension: Detection, evaluation, and treatment of renovascular hypertension: final report. Arch Int Med 1987;147:820-829.
6. Jacobson HR: Ischemic renal disease: An overlooked clinical entity? Kidney Int 1998;34:729-743.
7. Van Ampting JM, Penne EL, Beek FJ, Koomans HA, Boer WH, Beutler JJ: Prevalence of atherosclerosis renal artery stenosis in patients starting dialysis. Nephrol Dial Transplant 2003;18:1147-1151.
8. Cooper CJ, Murphy TP, Cutlip DE, Jamerson K, Henrich W, Reid DM, Cohen DJ, Matsumoto AH, Steffes M, Jaff MR, Prince MR, Lewis EF, Tuttle KR, Shapiro JI, Rundback JH, Massaro JM, D'Agostino RB, Dworkin LD, for the CORAL Investigators: Stenting and medical therapy fort atherosclerotic renal-artery stenosis. N Engl J Med 2014;370:13-22.
9. Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, Galanski M, Koch KM, Haller H: Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 2001;344:410-417.
10. Erley CM, Bader BD, berger ED, Tuncel N, Winkler S, Tepe G, Risler T, Duda S: Gadolinium-based contrast media compared with iodinate media. Nephrol Dial Transplant 2004;19:2526-2531.
11. Caps MT, Perissinotto C, Zierler RE, Polissar NL, Bergelin RO, Tullis MJ, Cantwell-Gab K, Davidson RC, Strandness DE Jr: Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998;98:2866-2872.
12. Wang Y, Ho DS, Chen WH, Wang YQ, Lam WF, Shen ZJ, Lu CZ, Chui M: Prevalence and predictors of renal artery stenosis in Chinese patients with coronary artery disease. Intern Med J 2003;33:280-285.
13. Hansen KJ, Edwards MS, Craven TE, Cherr GS, Jackson SA, Appel RG, Burke GL, Dean RH: Prevalence of renovascular disease in the elderly: A population-based study. J Vasc Surg 2002;36:443-451.
14. Coen G, Manni M, Giannoni MF, Bianchini G, Calabria S, Mantella D, Pigorini F, Taggi F: Ischemic nephropathy in an elderly nephrologic and hypertensive population. Am J Nephrol 1998;5:1806-1810.
15. Orth SR, Ritz E: The renal risks of smoking: An update. Curr Opin Nephrol Hypertens 2002;11:483-488.
16. Shukla AN, Madan TH, Jayaram AA, Kute VB, Rawal JR, Manjunath AP, Udhreja S: Prevalence and predictors of renal artery stenosis in patients undergoing peripheral and coronary angiography. Int Urol Nephrol 2013;45:1629-1635.
17. Sani SH, Hasanzadeh M, Gholoobi A, Alimi H, allah Esmaily H, Gifani M: Relationship between coronary and renal artery disease and associated risk factors in hypertensive and diabetic patients undergoing coronary angiography. Eurointervention 2008;4:373-377.
18. Paraskevas KI, Hamilton G, Cross JM, Mikhailidis DP: Atherosclerotic renal artery stenosis: Association with emerging vascular risk factors. Nephron Clin Pract 2008;108:56-66.
19. Catena C, Novello M, Lapenna R, Baroselli S, Colussi GL, Nadalini E, Favret G, Cavarape A, Soardo G, Sechi LA: New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a). J Hypertens 2005;23:1617-1631.
20. Sechi LA, Catena C, Casaccio D, Zingaro L: Lipoprotein(a), haemostatic variables and cardiovascular damage in hypertensive patients. J Hypertens 2000;18:709-716.
21. Park JS, Park JH, Yang WS, Kim SB, Park SW, Park SJ: Hyperfibrinogenemia as an independent risk factor for atherosclerotic renal artery stenosis. Am J Nephrol 1999;19:649-654.
22. Symonides B, Januszewicz A, Rowinski O, Januszewicz M, Chodakoska J, Berent H, Kuczynska K, Szmigielski C, Malek G, Januszewicz W: Plasma fibrinogen as a risk factor for restenosis after percutaneous transluminal renal angioplasty in patients with atherosclerotic renal artery stenosis. J Cardiovasc Risk 1999;6:269-272.
23. Olivieri O, Friso S, Trabetti E, Girelli D, Pizzolo F, Faccini G, Stranieri C, Pignatti PF, Corrocher R: Homocysteine and atheromatous renal artery stenosis. Clin Exp Med 2001;1:211-218.
24. Zhang Y, Ge J, Qian J, Ye Z: Prevalence and risk factors of atherosclerotic renal artery stenosis in 1.200 Chinese patients undergoing coronary angiography. Nephron Clin Pract 2006;104:185-192.
25. Scoble JE, de Takats D, Ostermann ME, Connolly JO, Scott NR, Beeso JA, Poyser KH, Peters TJ, Sherwood RA: Lipid profiles in patients with atherosclerotic renal artery stenosis. Nephron 1999;83:117-121.
26. Catena C, Zingaro L, Casaccio D, Sechi LA: Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance. Am J Med 2000;109:556-561.
27. Mancia G, De Backer G, Dominczak A, Cifkova R, Fagard R, Germanò G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B: 2007 ESH-ESC practice guidelines for the management of arterial hypertension. J Hypertens 2007;25:1105-1187.
28. Catena C, Novello M, Dotto L, De Marchi S, Sechi LA: Serum lipoprotein(a) concentrations and alcohol consumption in hypertension: possible relevance for cardiovascular damage. J Hypertens 2003;21:281-288.
29. Sechi LA, Di Fabio A, Bazzocchi M, Uzzau A, Catena C: Intrarenal hemodynamics in primary aldosteronism before and after treatment. J Clin Endocrinol Metab 2009;94:1191-1197.
30. Ramjee V, Sperling LS, Jacobson TA: Non-high density lipoprotein cholesterol versus apolipoprotein B in cardiovascular risk stratification: do the math. J Am Coll Cardiol 2011;58:457-463.
31. Sechi LA, Zingaro L, Catena C, Perin A, De Marchi S, Bartoli E: Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure. Kidney Int 1999;56:1049-1057.
32. Dati F, Tate JR, Marcovina SM, Steinmetz A: First WHO/IFCC International reference reagent for lipoprotein(a) for immunoassay-Lp(a) SRM 2B. Clin Chem Lab Med 2004;42:670-676.
33. Sechi LA, Zingaro L, Catena C, De Marchi S: Increased fibrinogen levels and hemostatic abnormalities in patients with arteriolar nephrosclerosis: Association with cardiovascular events. Thromb Haemost 2000;84:565-570.
34. Sechi LA, Novello M, Colussi GL, Di Fabio A, Chiuch A, Nadalini E, Casanova-Borca A, Uzzau A, Catena C: Relationship of plasma renin with a prothrombotic state in hypertension: relevance for organ damage. Am J Hypertens 2008;21:1347-1353.
35. Hoover-Plow J, Huang M: Lipoprotein(a) metabolism: potential sites for therapeutic targets. Metabolism 2013;62:479-491.
36. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH: Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest1992;90:52-60.
37. Kolski B, Tsimikas S: Emerging therapeutic agents to lower lipoprotein(a) levels. Curr Opin Lipidol 2012;23:560-568.
38. Seed M, O'Conner B, Perombelon N, O'Donnell M, Reaveley D, Knight BL: The effects of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover. Atherosclerosis 1993;101:61-68.
39. Colussi GL, Baroselli S, Sechi LA: Omega-3 polyunsaturated fatty acids decrease plasma lipoprotein(a) levels in hypertensive subjects. Clin Nutr 2004;3:1246-1247.
40. O'Donoghue M, Morrow DA, Tsimikas S, Sloan S, Ren AF, Hoffman EB, Desai NP, Solomon SD, Domanski M, Arai K, Chiuve SE, Cannon CP, Sacks FM, Sabatine MS: Lipoprotein(a) for Risk Assessment in Patients with Established Coronary Artery Disease. J Am Coll Cardiol 2014;63:520-527.
41. Nestel PJ, Barnes EH, Tonkin AM, Simes J, Fournier M, White HD, Colquhoun DM, Blankenberg S, Sullivan DR: Plasma Lipoprotein(a) Concentration Predicts Future Coronary and Cardiovascular Events in Patients With Stable Coronary Heart Disease. Arterioscler Thromb Vasc Biol 2013;33:2902-2908.
42. Sechi LA, Kronenberg F, De Carli S, Falleti E, Zingaro L, Catena C, Utermann G, Bartoli E: Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension. JAMA 1997;277:1689-1695.
43. Sechi LA, Zingaro L, Catena C, Casaccio D, De Marchi S: Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension. Hypertension 2000;36:978-985.
44. Dzielinska Z, Januszewicz A, Demkow M, Makowiecka-Ciesla M, Prejsbiz A, Naruszewicz M, Nowicka G, Kadziela J, Zielinski T, Florczak E, Janas J, Januszewicz M, Ruzyllo W: Cardiovascular risk factors in hypertensive patients with coronary artery disease and coexisting renal artery stenosis. J Hypertens 2007;25:663-670.
45. Minuz P, Patrignani P, Gaino S, Degan M, Menapace L, Tommasoli R, Seta F, Capone ML, Tacconelli S, Palatresi S, Bencini C, Del Vecchio C, Mansueto G, Arosio E, Santonastaso CL, Lechi A, Morganti A, Patrono C: Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation 2002;106:2800-2805.
46. Netea RT, Netea MG, Bredie SJ, Demaker PN, Hancu N, Thien T: Lipoprotein(a) concentrations in patients with familial combined hyperlipidemia and hypertension. Neth J Med 1999;55:39-45.
47. Sechi LA, Zingaro L, De Carli S, Sechi G, Catena C, Falleti E, Dell'Anna E, Bartoli E: Increased serum lipoprotein(a) levels in patients with early renal failure. Ann Intern Med 1998;129:457-461.